Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma

Translocation-associated renal cell carcinoma (TRCC) is a group of under-recognized malignant renal neoplasms owing to the unavailability of ancillary diagnostic tools and considering the fact that these tumors may histomorphologically mimic a heterogeneous group of neoplasms ranging from benign to malignant ones. Xp11.2 translocation-associated renal cell carcinoma is a disease of the young with a relatively less known prognosis owing to the rarity of such reported neoplasms. The histological appearance of bulbous tumor cells with abundant, vacuolated cytoplasm and the presence of psammomatoid bodies are clues to the diagnosis but are not entirely specific. The immunohistochemistry (IHC) finding of transcription factor E3 (TFE3) positivity is an important pointer, but the demonstration of Xp11.2 translocation by fluorescence in situ hybridization (FISH) serves as the confirmatory test. In our case report, we highlight the fact that a combined approach involving light microscopy, immunohistochemistry, and fluorescence in situ hybridization is the key to its diagnosis.

[1]  M. Rubin,et al.  The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2022, European urology.

[2]  Yuxiong Wang,et al.  Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review , 2020, The Journal of international medical research.

[3]  Richa Katiyar,et al.  MiT family translocation-associated (TFE3 positive) renal cell carcinoma of childhood , 2018, Indian journal of pathology & microbiology.

[4]  P. Argani,et al.  Xp11.2 translocation renal cell carcinoma , 2018, European Urology Supplements.

[5]  Y. Lai,et al.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report. , 2017, Molecular and clinical oncology.

[6]  K. Govindarajan,et al.  Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics , 2016, Journal of laboratory physicians.

[7]  J. Jeruc,et al.  Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype , 2014, Radiology and oncology.

[8]  P. Ahluwalia,et al.  Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature , 2013, Case reports in urology.

[9]  P. Camparo,et al.  Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  E. van den Berg,et al.  Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X;autosome translocations , 1995, Genes, chromosomes & cancer.

[11]  C. Pan,et al.  XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital. , 2011, Journal of the Chinese Medical Association : JCMA.

[12]  T. Chan World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs , 2005 .